首页 > 最新文献

Eurosurveillance最新文献

英文 中文
Highly pathogenic avian influenza management policy in domestic poultry: from reacting to preventing. 家禽高致病性禽流感管理政策:从应对到预防。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.42.2400266
Timothée Vergne, Mathilde C Paul, Claire Guinat, Mattias Delpont, Brandon H Hayes, Sébastien Lambert, Jean-Pierre Vaillancourt, Jean-Luc Guérin

The emergence of clade 2.3.4.4b H5N1 highly pathogenic avian influenza (HPAI) viruses in 2021 has led to unprecedented epidemics in poultry, changing epidemiological patterns of year-round infections in resident wild avifauna and more frequent spill-over events to mammals. Given this situation, it is important that we recognise that traditional HPAI management strategies are no longer sufficient, and policy changes are required. Poultry vaccination has emerged as a crucial intervention in the current control of HPAI, as evidenced by France's nationwide campaign targeting domestic ducks. However, due to the logistical challenges and potential trade implications of vaccination, broader structural reforms appear also necessary. These include a shift from farm-level to territorial-level biosecurity approaches, putting into practice the concept of 'regional biosecurity'. Given the role duck farm density has played in successive HPAI epidemics in France, there is a need to think about the spatial distribution of poultry farms as a structural component of regional biosecurity and to consider the reduction of farm concentration as a measure to prevent viral spread. The integration of regional biosecurity and poultry vaccination into prevention strategies should impact the way poultry are produced and traded in the future.

2021 年出现的 2.3.4.4b 支系 H5N1 高致病性禽流感(HPAI)病毒在家禽中引发了前所未有的流行病,改变了常住野生鸟类全年感染的流行病学模式,并更频繁地波及哺乳动物。鉴于这种情况,我们必须认识到,传统的高致病性禽流感管理策略已不再足够,必须改变政策。家禽疫苗接种已成为当前控制高致病性禽流感的一项重要干预措施,法国在全国范围内开展的针对家鸭的疫苗接种活动就证明了这一点。然而,由于疫苗接种带来的后勤挑战和潜在的贸易影响,更广泛的结构性改革似乎也是必要的。这包括从农场一级的生物安全方法转向地区一级的生物安全方法,将 "地区生物安全 "的概念付诸实践。鉴于鸭场密度在法国历次高致病性禽流感疫情中的作用,有必要将家禽养殖场的空间分布作为区域生物安全的一个结构性组成部分,并考虑将降低养殖场集中度作为预防病毒传播的一项措施。将区域生物安全和家禽疫苗接种纳入预防战略应影响未来家禽的生产和交易方式。
{"title":"Highly pathogenic avian influenza management policy in domestic poultry: from reacting to preventing.","authors":"Timothée Vergne, Mathilde C Paul, Claire Guinat, Mattias Delpont, Brandon H Hayes, Sébastien Lambert, Jean-Pierre Vaillancourt, Jean-Luc Guérin","doi":"10.2807/1560-7917.ES.2024.29.42.2400266","DOIUrl":"https://doi.org/10.2807/1560-7917.ES.2024.29.42.2400266","url":null,"abstract":"<p><p>The emergence of clade 2.3.4.4b H5N1 highly pathogenic avian influenza (HPAI) viruses in 2021 has led to unprecedented epidemics in poultry, changing epidemiological patterns of year-round infections in resident wild avifauna and more frequent spill-over events to mammals. Given this situation, it is important that we recognise that traditional HPAI management strategies are no longer sufficient, and policy changes are required. Poultry vaccination has emerged as a crucial intervention in the current control of HPAI, as evidenced by France's nationwide campaign targeting domestic ducks. However, due to the logistical challenges and potential trade implications of vaccination, broader structural reforms appear also necessary. These include a shift from farm-level to territorial-level biosecurity approaches, putting into practice the concept of 'regional biosecurity'. Given the role duck farm density has played in successive HPAI epidemics in France, there is a need to think about the spatial distribution of poultry farms as a structural component of regional biosecurity and to consider the reduction of farm concentration as a measure to prevent viral spread. The integration of regional biosecurity and poultry vaccination into prevention strategies should impact the way poultry are produced and traded in the future.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 42","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' correction for Euro Surveill. 2024;29(42). 作者对 Euro Surveill.2024;29(42).
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.43.241018c
{"title":"Authors' correction for Euro Surveill. 2024;29(42).","authors":"","doi":"10.2807/1560-7917.ES.2024.29.43.241018c","DOIUrl":"10.2807/1560-7917.ES.2024.29.43.241018c","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 43","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24. 6 至 59 个月儿童接种流感疫苗的效果:西班牙 2023/24 年初级保健和医院水平的测试阴性病例对照研究。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.40.2400618
Gloria Pérez-Gimeno, Clara Mazagatos, Nicola Lorusso, Luca Basile, Isabel Martínez-Pino, Francisca Corpas Burgos, Noa Batalla Rebolla, Mercedes B Rumayor Zarzuelo, Blanca Andreu Ivorra, Jaume Giménez Duran, Daniel Castrillejo, Inés Guiu Cañete, Marta Huerta Huerta, Marta García Becerril, Violeta Ramos Marín, Inmaculada Casas, Francisco Pozo, Susana Monge

During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza vaccine effectiveness (IVE) against any influenza type to be 70% (95% confidence interval (CI): 51 to 81%) for primary care patients with acute respiratory illness (ARI) and 77% (95% CI: 21 to 93%) for hospitalised patients with severe ARI. In primary care, where most subtyped viruses (61%; 145/237) were A(H1N1), adjusted IVE was 77% (95% CI: 56 to 88%) against A(H1N1)pdm09.

2023/24 年期间,西班牙全国所有 6 至 59 个月大的儿童都将接种季节性流感疫苗。通过使用哨点监测数据进行阴性病例对照设计,我们估计调整后的流感疫苗对任何流感类型的有效率(IVE)为:初级医疗机构的急性呼吸道疾病(ARI)患者为 70%(95% 置信区间:51% 至 81%),住院的严重急性呼吸道疾病患者为 77%(95% 置信区间:21% 至 93%)。在基层医疗机构,大多数亚型病毒(61%;145/237)都是 A(H1N1),针对 A(H1N1)pdm09 的调整 IVE 为 77%(95% CI:56% 至 88%)。
{"title":"Effectiveness of influenza vaccines in children aged 6 to 59 months: a test-negative case-control study at primary care and hospital level, Spain 2023/24.","authors":"Gloria Pérez-Gimeno, Clara Mazagatos, Nicola Lorusso, Luca Basile, Isabel Martínez-Pino, Francisca Corpas Burgos, Noa Batalla Rebolla, Mercedes B Rumayor Zarzuelo, Blanca Andreu Ivorra, Jaume Giménez Duran, Daniel Castrillejo, Inés Guiu Cañete, Marta Huerta Huerta, Marta García Becerril, Violeta Ramos Marín, Inmaculada Casas, Francisco Pozo, Susana Monge","doi":"10.2807/1560-7917.ES.2024.29.40.2400618","DOIUrl":"10.2807/1560-7917.ES.2024.29.40.2400618","url":null,"abstract":"<p><p>During 2023/24, all children aged 6 to 59 months were targeted for seasonal influenza vaccination in Spain nationally. Using a test-negative case-control design with sentinel surveillance data, we estimated adjusted influenza vaccine effectiveness (IVE) against any influenza type to be 70% (95% confidence interval (CI): 51 to 81%) for primary care patients with acute respiratory illness (ARI) and 77% (95% CI: 21 to 93%) for hospitalised patients with severe ARI. In primary care, where most subtyped viruses (61%; 145/237) were A(H1N1), adjusted IVE was 77% (95% CI: 56 to 88%) against A(H1N1)pdm09.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 40","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a European framework for the prevention of communicable diseases: three points for attention. 制定欧洲预防传染病框架:三点注意事项。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.43.2400306
Daniel H de Vries, Mandy Geise, Anna Christina Maukner, Piotr Kramarz, Charlotte Deogan, John Kinsman

The capacity to deliver programmes that prevent and control infectious diseases is a key public health function. The European Centre for Disease Prevention and Control (ECDC) aims to support and strengthen this capacity in European Union/ European Economic Area (EU/EEA) countries as part of its 2021-27 strategy which includes explicit attention to social and behavioural aspects of disease prevention. To achieve its strategic goals, it is important that ECDC improves its knowledge of prevention strategies, actors and activities in EU/EEA countries. In this Perspective, we summarise three challenges to implementing the prevention framework proposed by ECDC: (i) defining, recognising and identifying with 'prevention', (ii) integrating new understandings into established ways of thinking, and (iii) the need for more attention to prevention in governance. These challenges are derived from the findings of a project which conducted a preliminary mapping of prevention actors, networks and activities in four EU countries to support the development of a community of practice within the new ECDC prevention framework. This Perspective serves to draw attention to this prevention framework and the three identified challenges for those working on its implementation.

实施预防和控制传染病计划的能力是一项关键的公共卫生职能。欧洲疾病预防和控制中心(ECDC)旨在支持和加强欧盟/欧洲经济区(EU/EEA)国家的这种能力,这是其 2021-27 年战略的一部分,其中包括明确关注疾病预防的社会和行为方面。为实现其战略目标,欧盟疾病预防控制中心必须增进对欧盟/欧洲经济区国家预防战略、参与者和活动的了解。在本视角中,我们总结了实施欧洲疾病预防与控制中心提出的预防框架所面临的三个挑战:(i) 对 "预防 "的定义、认识和认同,(ii) 将新的理解融入既定的思维方式,(iii) 在治理中更加关注预防的必要性。这些挑战来自于一个项目的研究成果,该项目对四个欧盟国家的预防参与者、网络和活动进行了初步摸底,以支持在新的欧盟预防合作框架内发展一个实践社区。本《视角》旨在提请人们关注这一预防框架,以及为致力于实施该框架的人员所确定的三项挑战。
{"title":"Developing a European framework for the prevention of communicable diseases: three points for attention.","authors":"Daniel H de Vries, Mandy Geise, Anna Christina Maukner, Piotr Kramarz, Charlotte Deogan, John Kinsman","doi":"10.2807/1560-7917.ES.2024.29.43.2400306","DOIUrl":"10.2807/1560-7917.ES.2024.29.43.2400306","url":null,"abstract":"<p><p>The capacity to deliver programmes that prevent and control infectious diseases is a key public health function. The European Centre for Disease Prevention and Control (ECDC) aims to support and strengthen this capacity in European Union/ European Economic Area (EU/EEA) countries as part of its 2021-27 strategy which includes explicit attention to social and behavioural aspects of disease prevention. To achieve its strategic goals, it is important that ECDC improves its knowledge of prevention strategies, actors and activities in EU/EEA countries. In this Perspective, we summarise three challenges to implementing the prevention framework proposed by ECDC: (i) defining, recognising and identifying with 'prevention', (ii) integrating new understandings into established ways of thinking, and (iii) the need for more attention to prevention in governance. These challenges are derived from the findings of a project which conducted a preliminary mapping of prevention actors, networks and activities in four EU countries to support the development of a community of practice within the new ECDC prevention framework. This Perspective serves to draw attention to this prevention framework and the three identified challenges for those working on its implementation.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 43","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513761/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142497704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eurosurveillance annual theme 2025: Eurosurveillance opens submissions on vaccine-preventable diseases in humans - today's challenges and tomorrow's opportunities. 欧洲监测年度主题 2025:Eurosurveillance 就人类可用接种疫苗预防的疾病--当今的挑战和未来的机遇--公开征文。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.40.031024mis
{"title":"<i>Eurosurveillance</i> annual theme 2025: <i>Eurosurveillance</i> opens submissions on vaccine-preventable diseases in humans - today's challenges and tomorrow's opportunities.","authors":"","doi":"10.2807/1560-7917.ES.2024.29.40.031024mis","DOIUrl":"10.2807/1560-7917.ES.2024.29.40.031024mis","url":null,"abstract":"","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 40","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Airport and luggage (Odyssean) malaria in Europe: a systematic review. 欧洲的机场和行李(奥德赛)疟疾:系统回顾。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.41.2400237
Luisa K Hallmaier-Wacker, Merel D van Eick, Olivier Briët, Hugues Delamare, Gerhard Falkenhorst, Sandrine Houzé, Harold Noël, Javiera Rebolledo, Wim Van Bortel, Céline M Gossner

BackgroundAirport and luggage (also called Odyssean) malaria are chance events where Plasmodium infection results from the bite of an infected mosquito which was transported by aircraft from a malaria-endemic area. Infrequent case reports and a lack of central data collection challenge a comprehensive overview.AimTo update the epidemiological, clinical and biological understanding of airport and luggage malaria cases in Europe.MethodsWe conducted a systematic review of studies indexed from 1969 to January 2024 in MEDLINE, Embase and OpenGrey databases. A data call to EU/EEA and UK public health institutes was launched in December 2022.ResultsOf the 145 cases (89 cases from 48 studies and 56 cases from the data call) described from nine countries, 105 were classified as airport malaria, 32 as luggage malaria and eight as either airport or luggage malaria. Most airport malaria cases were reported in France (n = 52), Belgium (n = 19) and Germany (n = 9). Half of cases resided or worked near or at an international airport (mean distance of 4.3 km, n = 28). Despite disruptions in air travel amid the COVID-19 pandemic, one third of cases reported since 2000 occurred between 2018 and 2022, with a peak in 2019.ConclusionWhile airport and luggage malaria cases are rare, reports in Europe have increased, highlighting the need for effective prevention measures and a more structured surveillance of cases in Europe. Prevention measures already in place such as aircraft disinsection should be assessed for compliance and effectiveness.

背景机场和行李(也称奥德赛)疟疾是一种偶然事件,疟原虫感染是由于受感染的蚊子叮咬了从疟疾流行地区乘飞机来的蚊子。我们对 MEDLINE、Embase 和 OpenGrey 数据库中 1969 年至 2024 年 1 月索引的研究进行了系统回顾。结果在来自 9 个国家的 145 个病例(89 个病例来自 48 项研究,56 个病例来自数据征集)中,105 个病例被归类为机场疟疾,32 个病例被归类为行李疟疾,8 个病例被归类为机场疟疾或行李疟疾。大多数机场疟疾病例发生在法国(52 例)、比利时(19 例)和德国(9 例)。半数病例居住或工作在国际机场附近或机场内(平均距离 4.3 千米,n = 28)。尽管在 COVID-19 大流行期间航空旅行受到干扰,但自 2000 年以来报告的病例中有三分之一发生在 2018 年至 2022 年期间,其中 2019 年达到高峰。结论虽然机场和行李箱疟疾病例很少见,但欧洲的报告有所增加,这突出表明需要采取有效的预防措施,并对欧洲的病例进行更有组织的监测。应评估已实施的预防措施(如飞机消毒)的合规性和有效性。
{"title":"Airport and luggage (Odyssean) malaria in Europe: a systematic review.","authors":"Luisa K Hallmaier-Wacker, Merel D van Eick, Olivier Briët, Hugues Delamare, Gerhard Falkenhorst, Sandrine Houzé, Harold Noël, Javiera Rebolledo, Wim Van Bortel, Céline M Gossner","doi":"10.2807/1560-7917.ES.2024.29.41.2400237","DOIUrl":"10.2807/1560-7917.ES.2024.29.41.2400237","url":null,"abstract":"<p><p>BackgroundAirport and luggage (also called Odyssean) malaria are chance events where <i>Plasmodium</i> infection results from the bite of an infected mosquito which was transported by aircraft from a malaria-endemic area. Infrequent case reports and a lack of central data collection challenge a comprehensive overview.AimTo update the epidemiological, clinical and biological understanding of airport and luggage malaria cases in Europe.MethodsWe conducted a systematic review of studies indexed from 1969 to January 2024 in MEDLINE, Embase and OpenGrey databases. A data call to EU/EEA and UK public health institutes was launched in December 2022.ResultsOf the 145 cases (89 cases from 48 studies and 56 cases from the data call) described from nine countries, 105 were classified as airport malaria, 32 as luggage malaria and eight as either airport or luggage malaria. Most airport malaria cases were reported in France (n = 52), Belgium (n = 19) and Germany (n = 9). Half of cases resided or worked near or at an international airport (mean distance of 4.3 km, n = 28). Despite disruptions in air travel amid the COVID-19 pandemic, one third of cases reported since 2000 occurred between 2018 and 2022, with a peak in 2019.ConclusionWhile airport and luggage malaria cases are rare, reports in Europe have increased, highlighting the need for effective prevention measures and a more structured surveillance of cases in Europe. Prevention measures already in place such as aircraft disinsection should be assessed for compliance and effectiveness.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 41","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020. 2020 年,瑞典,早期未被发现的 SARS-CoV-2 引入形成了第一波大流行。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.41.2400021
Robert Dyrdak, Emma B Hodcroft, Sandra Broddesson, Malin Grabbe, Hildur Franklin, Magnus Gisslén, Maricris E Holm, Magnus Lindh, Joanna Nederby-Öhd, Johan Ringlander, Martin Sundqvist, Richard A Neher, Jan Albert

BackgroundDespite the unprecedented measures implemented globally in early 2020 to prevent the spread of SARS-CoV-2, Sweden, as many other countries, experienced a severe first wave during the COVID-19 pandemic.AimWe investigated the introduction and spread of SARS-CoV-2 into Sweden.MethodsWe analysed stored respiratory specimens (n = 1,979), sampled 7 February-2 April 2020, by PCR for SARS-CoV-2 and sequenced PCR-positive specimens. Sequences generated from newly detected cases and stored positive specimens February-June 2020 (n = 954) were combined with sequences (Sweden: n = 730; other countries: n = 129,913) retrieved from other sources for Nextstrain clade assignment and phylogenetic analyses.ResultsTwelve previously unrecognised SARS-CoV-2 cases were identified: the earliest was sampled on 3 March, 1 week before recognised community transmission. We showed an early influx of clades 20A and 20B from Italy (201/328, 61% of cases exposed abroad) and clades 19A and 20C from Austria (61/328, 19%). Clade 20C dominated the first wave (20C: 908/1,684, 54%; 20B: 438/1,684, 26%; 20A: 263/1,684, 16%), and 800 of 1,684 (48%) Swedish sequences formed a country-specific 20C cluster defined by a spike mutation (G24368T). At the regional level, the proportion of clade 20C sequences correlated with an earlier weighted mean date of COVID-19 deaths.ConclusionCommunity transmission in Sweden started when mitigation efforts still focused on preventing influx. This created a transmission advantage for clade 20C, likely introduced from ongoing cryptic spread in Austria. Therefore, pandemic preparedness should have a comprehensive approach, including capacity for large-scale diagnostics to allow early detection of travel-related cases and community transmission.

Aimwe investigated the introduction and spread of SARS-CoV-2 into Sweden.Methods We analyzed stored respiratory specimens (n = 1,979), sampled 7 February-2 April 2020, by PCR for SARS-CoV-2 and sequencing PCR-positive specimens.我们调查了SARS-CoV-2在瑞典的传播情况。从新发现的病例和 2020 年 2 月至 6 月储存的阳性标本(n = 954)中生成的序列与从其他来源检索到的序列(瑞典:n = 730;其他国家:n = 129,913)相结合,进行 Nextstrain 支系分配和系统发生学分析。我们发现来自意大利的 20A 和 20B 支系(201/328,占国外感染病例的 61%)和来自奥地利的 19A 和 20C 支系(61/328,占 19%)在早期大量涌入。20C支系在第一波中占主导地位(20C:908/1,684,54%;20B:438/1,684,26%;20A:263/1,684,16%),在1,684个瑞典序列中,有800个(48%)形成了一个由尖峰突变(G24368T)定义的国家特异性20C群。在地区层面,20C支系序列的比例与较早的 COVID-19 死亡加权平均日期相关。这为 20C 支系创造了传播优势,而 20C 支系很可能是从奥地利的隐性传播中引入的。因此,大流行病防备工作应采取综合方法,包括大规模诊断能力,以便及早发现与旅行有关的病例和社区传播。
{"title":"Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020.","authors":"Robert Dyrdak, Emma B Hodcroft, Sandra Broddesson, Malin Grabbe, Hildur Franklin, Magnus Gisslén, Maricris E Holm, Magnus Lindh, Joanna Nederby-Öhd, Johan Ringlander, Martin Sundqvist, Richard A Neher, Jan Albert","doi":"10.2807/1560-7917.ES.2024.29.41.2400021","DOIUrl":"10.2807/1560-7917.ES.2024.29.41.2400021","url":null,"abstract":"<p><p>BackgroundDespite the unprecedented measures implemented globally in early 2020 to prevent the spread of SARS-CoV-2, Sweden, as many other countries, experienced a severe first wave during the COVID-19 pandemic.AimWe investigated the introduction and spread of SARS-CoV-2 into Sweden.MethodsWe analysed stored respiratory specimens (n = 1,979), sampled 7 February-2 April 2020, by PCR for SARS-CoV-2 and sequenced PCR-positive specimens. Sequences generated from newly detected cases and stored positive specimens February-June 2020 (n = 954) were combined with sequences (Sweden: n = 730; other countries: n = 129,913) retrieved from other sources for Nextstrain clade assignment and phylogenetic analyses.ResultsTwelve previously unrecognised SARS-CoV-2 cases were identified: the earliest was sampled on 3 March, 1 week before recognised community transmission. We showed an early influx of clades 20A and 20B from Italy (201/328, 61% of cases exposed abroad) and clades 19A and 20C from Austria (61/328, 19%). Clade 20C dominated the first wave (20C: 908/1,684, 54%; 20B: 438/1,684, 26%; 20A: 263/1,684, 16%), and 800 of 1,684 (48%) Swedish sequences formed a country-specific 20C cluster defined by a spike mutation (G24368T). At the regional level, the proportion of clade 20C sequences correlated with an earlier weighted mean date of COVID-19 deaths.ConclusionCommunity transmission in Sweden started when mitigation efforts still focused on preventing influx. This created a transmission advantage for clade 20C, likely introduced from ongoing cryptic spread in Austria. Therefore, pandemic preparedness should have a comprehensive approach, including capacity for large-scale diagnostics to allow early detection of travel-related cases and community transmission.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 41","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142399844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly pathogenic avian influenza (HPAI) H5 virus exposure in domestic cats and rural stray cats, the Netherlands, October 2020 to June 2023. 2020 年 10 月至 2023 年 6 月荷兰家猫和农村流浪猫接触高致病性禽流感 (HPAI) H5 病毒的情况。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.44.2400326
Mirjam B H M Duijvestijn, Nancy N M P Schuurman, Johannes C M Vernooij, Michelle A J M van Leeuwen, Judith M A van den Brand, Jaap A Wagenaar, Frank J M van Kuppeveld, Herman F Egberink, Cornelis A M de Haan, Josanne H Verhagen

BackgroundHighly pathogenic avian influenza (HPAI) H5Nx and human H1N1pdm2009 influenza viruses can infect cats. Infections in cats may result in viral adaptations or recombinant viruses, which may facilitate zoonotic transfer.AimWe aimed to investigate the presence of HPAI H5 clade 2.3.4.4 and H1 influenza viruses and antibodies to these viruses in domestic and rural stray cats in the Netherlands and factors associated with exposure.MethodsSera from stray and domestic cats, sampled 2020-2023, were analysed by ELISA and confirmed by hemagglutination inhibition assay (HAI) and pharyngeal swabs and lung tissue for influenza A virus by RT-qPCR.ResultsIn 701 stray cats, 83 (11.8%; 95% confidence interval (CI): 9.5-14.5) sera were positive for HPAI H5 and 65 findings were confirmed. In HAI, two sera were positive for both HPAI H5 and H1. In 871 domestic cats, four (0.46%; 95% CI: 0.13-1.2) sera were HPAI H5 positive and none were confirmed but 40 (4.6%; 95% CI: 3.3-6.2) sera were seropositive for H1 and 26 were confirmed. Stray cats living in nature reserves (odds ratio (OR) = 5.4; 95% CI: 1.5-20.1) and older cats (OR = 3.8; 95% CI: 2.7-7.1) were more likely to be HPAI H5 seropositive. No influenza A virus was detected in 230 cats.ConclusionThe higher HPAI H5 seroprevalence in stray cats compared with domestic cats suggests more frequent viral exposure, most likely due to foraging on wild birds. In contrast, exposure to H1 was more common in domestic cats compared with stray cats.

背景高致病性禽流感(HPAI)H5Nx和人类H1N1pdm2009流感病毒可感染猫。我们的目的是调查荷兰家猫和农村流浪猫中是否存在高致病性禽流感 H5 2.3.4.4 支系和 H1 流感病毒及这些病毒的抗体,以及与暴露相关的因素。结果 在 701 只流浪猫中,83 份(11.8%;95% 置信区间 (CI):9.5-14.5)血清对高致病性禽流感 H5 呈阳性,65 份结果得到证实。在 HAI 中,有 2 份血清对高致病性禽流感 H5 和 H1 均呈阳性。在 871 只家猫中,有 4 份(0.46%;95% CI:0.13-1.2)血清对高致病性禽流感 H5 呈阳性,其中无猫被确诊,但有 40 份(4.6%;95% CI:3.3-6.2)血清对 H1 呈阳性,其中 26 份被确诊。居住在自然保护区的流浪猫(几率比(OR)=5.4;95% CI:1.5-20.1)和年龄较大的猫(OR=3.8;95% CI:2.7-7.1)更有可能对高致病性禽流感 H5 病毒呈血清阳性。结论与家猫相比,流浪猫的高致病性禽流感 H5 血清阳性率较高,这表明流浪猫接触病毒的频率较高,很可能是由于觅食野鸟所致。相比之下,家猫比流浪猫更常接触 H1 病毒。
{"title":"Highly pathogenic avian influenza (HPAI) H5 virus exposure in domestic cats and rural stray cats, the Netherlands, October 2020 to June 2023.","authors":"Mirjam B H M Duijvestijn, Nancy N M P Schuurman, Johannes C M Vernooij, Michelle A J M van Leeuwen, Judith M A van den Brand, Jaap A Wagenaar, Frank J M van Kuppeveld, Herman F Egberink, Cornelis A M de Haan, Josanne H Verhagen","doi":"10.2807/1560-7917.ES.2024.29.44.2400326","DOIUrl":"10.2807/1560-7917.ES.2024.29.44.2400326","url":null,"abstract":"<p><p>BackgroundHighly pathogenic avian influenza (HPAI) H5Nx and human H1N1pdm2009 influenza viruses can infect cats. Infections in cats may result in viral adaptations or recombinant viruses, which may facilitate zoonotic transfer.AimWe aimed to investigate the presence of HPAI H5 clade 2.3.4.4 and H1 influenza viruses and antibodies to these viruses in domestic and rural stray cats in the Netherlands and factors associated with exposure.MethodsSera from stray and domestic cats, sampled 2020-2023, were analysed by ELISA and confirmed by hemagglutination inhibition assay (HAI) and pharyngeal swabs and lung tissue for influenza A virus by RT-qPCR.ResultsIn 701 stray cats, 83 (11.8%; 95% confidence interval (CI): 9.5-14.5) sera were positive for HPAI H5 and 65 findings were confirmed. In HAI, two sera were positive for both HPAI H5 and H1. In 871 domestic cats, four (0.46%; 95% CI: 0.13-1.2) sera were HPAI H5 positive and none were confirmed but 40 (4.6%; 95% CI: 3.3-6.2) sera were seropositive for H1 and 26 were confirmed. Stray cats living in nature reserves (odds ratio (OR) = 5.4; 95% CI: 1.5-20.1) and older cats (OR = 3.8; 95% CI: 2.7-7.1) were more likely to be HPAI H5 seropositive. No influenza A virus was detected in 230 cats.ConclusionThe higher HPAI H5 seroprevalence in stray cats compared with domestic cats suggests more frequent viral exposure, most likely due to foraging on wild birds. In contrast, exposure to H1 was more common in domestic cats compared with stray cats.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 44","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological analysis of confirmed mpox cases, Burundi, 3 July to 9 September 2024. 布隆迪水痘确诊病例的流行病学分析,2024 年 7 月 3 日至 9 月 9 日。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-10-01 DOI: 10.2807/1560-7917.ES.2024.29.42.2400647
Alexis Nizigiyimana, Francois Ndikumwenayo, Sarah Houben, Martin Manirakiza, Monique van Lettow, Laurens Liesenborghs, Placide Mbala-Kingebeni, Anne W Rimoin, Isaac I Bogoch, Jason Kindrachuk

We analysed mpox cases in Burundi from July to September 2024, following the introduction of Clade Ib virus. Of 607 samples from the whole population of suspected cases, 154 were PCR-positive, of whom 85 were children under 15 years, with a higher proportion of female children testing positive. Geographical analysis demonstrates case concentration in Bujumbura Mairie (91/154). Age- and sex-specific interventions, as well as community engagement, are important for outbreak containment, as are targeted public health strategies in Burundi.

我们分析了 2024 年 7 月至 9 月布隆迪引入 Ib 支系病毒后的麻疹病例。在所有疑似病例的 607 份样本中,有 154 份呈 PCR 阳性,其中 85 人是 15 岁以下的儿童,女性儿童呈阳性的比例较高。地域分析表明,病例集中在布琼布拉市(91/154)。针对不同年龄和性别的干预措施以及社区参与对于遏制疫情十分重要,布隆迪有针对性的公共卫生战略也是如此。
{"title":"Epidemiological analysis of confirmed mpox cases, Burundi, 3 July to 9 September 2024.","authors":"Alexis Nizigiyimana, Francois Ndikumwenayo, Sarah Houben, Martin Manirakiza, Monique van Lettow, Laurens Liesenborghs, Placide Mbala-Kingebeni, Anne W Rimoin, Isaac I Bogoch, Jason Kindrachuk","doi":"10.2807/1560-7917.ES.2024.29.42.2400647","DOIUrl":"https://doi.org/10.2807/1560-7917.ES.2024.29.42.2400647","url":null,"abstract":"<p><p>We analysed mpox cases in Burundi from July to September 2024, following the introduction of Clade Ib virus. Of 607 samples from the whole population of suspected cases, 154 were PCR-positive, of whom 85 were children under 15 years, with a higher proportion of female children testing positive. Geographical analysis demonstrates case concentration in Bujumbura Mairie (91/154). Age- and sex-specific interventions, as well as community engagement, are important for outbreak containment, as are targeted public health strategies in Burundi.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 42","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142461412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023. 荷兰,2022 年至 2023 年,高危人群接种 MVA-BN 疫苗 1 年后,正畸病毒特异性抗体降至检测不到的水平。
IF 9.9 2区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2024-09-01 DOI: 10.2807/1560-7917.ES.2024.29.38.2400575
Leanne Pm van Leeuwen, Marc C Shamier, Babs E Verstrepen, Hannelore M Götz, Katharina S Schmitz, Najlae Akhiyate, Koen Wijnans, Susanne Bogers, Martin E van Royen, Eric Cm van Gorp, Marion Pg Koopmans, Rory D de Vries, Corine H GeurtsvanKessel, Luca M Zaeck

In response to the mpox outbreak in 2022 and 2023, widespread vaccination with modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as JYNNEOS or Imvanex) was initiated. Here, we demonstrate that orthopoxvirus-specific binding and MVA-neutralising antibodies waned to undetectable levels 1 year post vaccination in at-risk individuals who received two doses of MVA-BN administered subcutaneously with an interval of 4 weeks, without prior smallpox or mpox vaccination. Continuous surveillance is essential to understand the impact of declining antibody levels.

为应对 2022 年和 2023 年的 mpox 疫情,启动了改良安卡拉-巴伐利亚-北欧(MVA-BN,又称 JYNNEOS 或 Imvanex)疫苗的广泛接种。在这里,我们证明了在没有接种天花或水痘疫苗的情况下,接种两剂间隔 4 周的 MVA-BN 皮下注射的高危人群中,正痘特异性结合抗体和 MVA 中和抗体在接种后 1 年减弱到检测不到的水平。持续监测对于了解抗体水平下降的影响至关重要。
{"title":"Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023.","authors":"Leanne Pm van Leeuwen, Marc C Shamier, Babs E Verstrepen, Hannelore M Götz, Katharina S Schmitz, Najlae Akhiyate, Koen Wijnans, Susanne Bogers, Martin E van Royen, Eric Cm van Gorp, Marion Pg Koopmans, Rory D de Vries, Corine H GeurtsvanKessel, Luca M Zaeck","doi":"10.2807/1560-7917.ES.2024.29.38.2400575","DOIUrl":"10.2807/1560-7917.ES.2024.29.38.2400575","url":null,"abstract":"<p><p>In response to the mpox outbreak in 2022 and 2023, widespread vaccination with modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as JYNNEOS or Imvanex) was initiated. Here, we demonstrate that orthopoxvirus-specific binding and MVA-neutralising antibodies waned to undetectable levels 1 year post vaccination in at-risk individuals who received two doses of MVA-BN administered subcutaneously with an interval of 4 weeks, without prior smallpox or mpox vaccination. Continuous surveillance is essential to understand the impact of declining antibody levels.</p>","PeriodicalId":12161,"journal":{"name":"Eurosurveillance","volume":"29 38","pages":""},"PeriodicalIF":9.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484288/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142282652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eurosurveillance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1